88 related articles for article (PubMed ID: 22789731)
21. Therapeutic indications in oncology: emerging features and regulatory dynamics.
Tafuri G; Leufkens HG; Laing R; Trotta F
Eur J Cancer; 2010 Feb; 46(3):471-5. PubMed ID: 20056536
[TBL] [Abstract][Full Text] [Related]
22. Satisfaction with pharmacotherapy for approved and off-label indications--a Delphi study.
Kos M; Wertheimer AI; Mrhar A
Ann Pharmacother; 2005 Apr; 39(4):649-54. PubMed ID: 15755789
[TBL] [Abstract][Full Text] [Related]
23. Off-label prescribing patterns of antidepressants in children and adolescents.
Lee E; Teschemaker AR; Johann-Liang R; Bazemore G; Yoon M; Shim KS; Daniel M; Pittman J; Wutoh AK
Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):137-44. PubMed ID: 21538674
[TBL] [Abstract][Full Text] [Related]
24. [Off-label drug prescriptions among outpatient children and adolescents in Germany--a database analysis].
Sonntag D; Trebst D; Kiess W; Kapellen T; Bertsche T; Kostev K
Dtsch Med Wochenschr; 2013 Oct; 138(44):2239-45. PubMed ID: 24150699
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of drug therapy prescribed in special situations at hospital.
González-Morcillo G; Calderón-Hernanz B; Rodríguez-Camacho JM
Farm Hosp; 2020 Oct; 44(6):272-278. PubMed ID: 33156745
[TBL] [Abstract][Full Text] [Related]
26. Unapproved uses of approved drugs: the physician, the package insert, and the Food and Drug Administration: subject review. American Academy of Pediatrics Committee on Drugs.
Pediatrics; 1996 Jul; 98(1):143-5. PubMed ID: 8668390
[TBL] [Abstract][Full Text] [Related]
27. [Study of rituximab efficacy, cost, safety, and compliance of its package leaflet in a tertiary hospital].
Conde García MC; Fernández Feijoo MA; Calleja Hernández MA
Farm Hosp; 2009; 33(6):305-11. PubMed ID: 20038389
[TBL] [Abstract][Full Text] [Related]
28. Review of oncology and hematology drug product approvals at the US Food and Drug Administration between July 2005 and December 2007.
Sridhara R; Johnson JR; Justice R; Keegan P; Chakravarty A; Pazdur R
J Natl Cancer Inst; 2010 Feb; 102(4):230-43. PubMed ID: 20118413
[TBL] [Abstract][Full Text] [Related]
29. [Off-label prescription: practice and problems].
Carneiro AV; Costa J
Rev Port Cardiol; 2013 Sep; 32(9):681-6. PubMed ID: 23896300
[TBL] [Abstract][Full Text] [Related]
30. Evaluating a restrictive formulary system by assessing nonformulary-drug requests.
Green JA; Chawla AK; Fong PA
Am J Hosp Pharm; 1985 Jul; 42(7):1537-41. PubMed ID: 4025350
[TBL] [Abstract][Full Text] [Related]
31. Off-label prescribing during pregnancy in the UK: an analysis of 18,000 prescriptions in Liverpool Women's Hospital.
Herring C; McManus A; Weeks A
Int J Pharm Pract; 2010 Aug; 18(4):226-9. PubMed ID: 20636674
[TBL] [Abstract][Full Text] [Related]
32. Off-label use of drugs in pain medicine and palliative care: an algorithm for the assessment of its safe and legal prescription.
Verhagen CC; Niezink AG; Engels YY; Hekster YY; Doornebal JJ; Vissers KC
Pain Pract; 2008; 8(3):157-63. PubMed ID: 18373512
[TBL] [Abstract][Full Text] [Related]
33. [Cost-effectiveness of new drugs impacts reimbursement decision making but room for improvement].
Hoomans T; van der Roer N; Severens JL; Delwel GO
Ned Tijdschr Geneeskd; 2010; 154():A958. PubMed ID: 20699045
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of off-label drug uses in hospitals: a multicentric prospective study.
Danés I; Agustí A; Vallano A; Alerany C; Martínez J; Bosch JA; Ferrer A; Gratacós L; Pérez A; Olmo M; Marron SM; Valderrama A; Bonafont X
Eur J Clin Pharmacol; 2014 Nov; 70(11):1385-93. PubMed ID: 25196202
[TBL] [Abstract][Full Text] [Related]
35. Use of non-formulary high-cost medicines in an Australian public hospital.
Inglis JM; Caughey GE; Shakib S
Int J Clin Pharm; 2019 Aug; 41(4):920-931. PubMed ID: 31161497
[TBL] [Abstract][Full Text] [Related]
36. [Status and analysis of off-label drug use in department of ophthalmology].
Han FR; Zhao HY; Li L; Wang JW
Zhonghua Yan Ke Za Zhi; 2017 Apr; 53(4):300-304. PubMed ID: 28412804
[No Abstract] [Full Text] [Related]
37. Drug utilization and off-label drug use in Spanish pediatric gastroenterology outpatients.
Ruíz-Antorán B; Piñeiro R; Avendaño C; Román E; Cilleruelo ML; Gutiérrez-Junquera C; Centeno G; Cilleruelo MJ
J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):173-7. PubMed ID: 23328455
[TBL] [Abstract][Full Text] [Related]
38. Off-label medication use.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2012 Sep; 50(9):11-3. PubMed ID: 22897212
[TBL] [Abstract][Full Text] [Related]
39. Off-label use of anti-cancer drugs in India: to be or not to be!
Gota V; Patial P
J Cancer Res Ther; 2011; 7(1):35-9. PubMed ID: 21546740
[TBL] [Abstract][Full Text] [Related]
40. Development and implementation of an academic cancer therapy stewardship program.
Steinberg AS; Parikh AB; Kim S; Peralta-Hernandez D; Aggour T; Isola L
Am J Manag Care; 2018 Mar; 24(3):147-151. PubMed ID: 29553276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
